Orphan Medicinal Products and patient Advocacy Group

Orphan drugs are medicinal products that are used to treat rare diseases. They are called “orphan drugs” because due to their limited in market, only few pharmaceutical companies pursue research into such products. These drugs would not be produce without government assistance.

List of orphan medicinal products in Europe with European orphan designation

 

  • Adcetris
  • Adempas
  • Hetlioz
  • ChenodeoxycHolicAcidLeadiant
  • Besponsa
  • Iclusig
  • Ketoconazlehra
  • Namuscla
  • Roxon

Related Conference of Orphan Medicinal Products and patient Advocacy Group

November 28-29, 2024

20th World Congress on Infection Prevention and Control

Paris, France
March 13-14, 2025

9th International Conference on Rare Diseases

Prague, Czech Republic
March 17-18, 2025

12th International Congress on Infectious Diseases

Berlin, Germany
April 14-15, 2025

15th European Epidemiology and Public Health Congress

Budapest, Hungary
June 02-03, 2025

14th World Congress on Rare Diseases and Orphan Drugs

Amsterdam, Netherlands
June 02-03, 2025

17th Euro-Global Conference on Infectious Diseases

Amsterdam, Netherlands

Orphan Medicinal Products and patient Advocacy Group Conference Speakers

    Recommended Sessions

    Related Journals

    Are you interested in